News and Announcements
Proteomics International Laboratories Ltd CEO Interview
- Published February 04, 2015 12:19PM UTC
- Publisher Wholesale Investor
- Categories Executive Interviews
Proteomics International Laboratories Ltd (PILL) is an innovative biological research and drug discovery company specialising in the development of simple diagnostic tests for common diseases and the discovery of new therapeutic drugs to treat pain and infection. The Company, based in Perth, Western Australia, works across three units – diagnostics, therapeutics and analytical services.
The Company now seeks additional funding of $6 million to expand each business unit and accelerate commercialisation. It focuses on utilising the funds raised to commercialise the already-developed IP, and implement a measured programme for further compound discovery, whilst expanding existing revenues to underpin future efforts.
To find out more about PILL please listen to Dr Richard Lipscombe, Managing Director.
Executive Interviews
Forget the share price. SpaceX just published a map of the next five years.
Most coverage of SpaceX’s result focused on a 9.1% share price fall. That is noise. The signal is in the transcript: compute, power, bandwidth and demand over the next five years.
The prefab company that deliberately leaves part of the house unbuilt
BuiltQuik prefabricates the floor and roof structure and stops there. Co-founder Ryan Mullaney argues the omission is the product. Prefabricated housing usually means a factory. A large central facility, identical modules, limited room to move on design, and a logistics problem getting the finished box to site. BuiltQuik builds the opposite, and the design decision […]
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets
QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]
Backed By Leading Investment Groups and Family Offices
